Physician profile
Dwayne V Ford
NPI 1942854773
$1,228.08
in general payments reported to CMS, 2019-2025
23 companies · $991 in 2025
The $991 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.50 · 2024: $225 · 2025: $991.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,212 · Education: $4.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,211.73 |
| Education | $4.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $231.84 | 2024-2025 | Gemtesa |
| Dendreon Pharmaceuticals LLC | $148.49 | 2024-2025 | Provenge |
| Ferring Pharmaceuticals INC. | $99.35 | 2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $73.48 | 2025 | |
| Astellas Pharma US INC | $66.37 | 2025 | Xtandi, Padcev |
| Progenics Pharmaceuticals, INC. | $66.10 | 2024-2025 | |
| C. R. Bard, INC. & Subsidiaries | $64.41 | 2025 | Bard Urinary Drainage Bag |
| Verity Pharmaceuticals INC. | $48.62 | 2025 | Tlando, Trelstar |
| Olympus America INC. | $43.20 | 2025 | Itind System |
| Teleflex LLC | $42.02 | 2025 | Barrigel, Urolift |
| Merck Sharp & Dohme LLC | $41.70 | 2024-2025 | Keytruda |
| Novartis Pharmaceuticals Corporation | $40.80 | 2025 | |
| Myriad Genetic Laboratories, INC. | $38.14 | 2025 | Prolaris |
| Convatec INC. | $35.85 | 2024 | |
| 180 Medical, INC. | $29.08 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $26.79 | 2025 | Eligard, Jatenzo |
| Novo Nordisk INC | $24.92 | 2024 | |
| Blue Earth Diagnostics | $22.81 | 2025 | Posluma |
| Ambu INC. | $19.25 | 2025 | |
| Calyxo, INC. | $18.50 | 2025 | Cvac Aspiration System |
| Endo USA, INC. | $18.04 | 2025 | Xiaflex |
| Abc Home Medical Supply, INC. | $16.82 | 2025 | |
| Resmed Corp | $11.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dwayne Ford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.